Zynex Q2 revenue plunges 55% to $22.3M, net loss $20M; suspends guidance, appoints new CEO

ZYNEX INC

2025-Q2 EPS reported -$0.98 revenue$48,868,000

Revenue $22.3M (down 55% YoY); net loss $20.0M ($0.66 per share) vs net income $1.2M in Q2 2024.
Adjusted EBITDA loss $8.9M vs $3.5M prior year; gross margin fell to 68% from 80%.
Cash collections $26.1M; operating cash flow deficit ($6.2M) in Q2, cash $17.5M at June 30.
Appointed Steven Dyson as new CEO; current CEO retiring, CFO departing; guidance suspended pending review.
Submitted NiCO laser pulse oximeter to FDA; annualized cost savings of ~$40M targeted from Q3/Q4.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.